Evidence map›Paper›PMID 32617185›Full record

ArticleACS catalysis2019

Cu-Catalyzed Hydroboration of Benzylidenecyclopropanes: Reaction Optimization, (Hetero)Aryl Scope, and Origins of Pathway Selectivity.

Jose M Medina, Taeho Kang, Tuğçe G Erbay, Huiling Shao, Gary M Gallego, Shouliang Yang, Michelle Tran-Dubé, Paul F Richardson, Joseph Derosa, Ryan T Helsel and 7 more

Abstract read
In one paragraph

Article in ACS catalysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Borylcyclopropanes: Synthetic Strategies and Applications.Angewandte Chemie (International ed. in English) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Hydroboration of Terminal Alkenes andAngewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jose M Medina *Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Taeho Kang *Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Tuğçe G ErbayDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.
Huiling ShaoDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.
Gary M GallegoPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Shouliang YangPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Michelle Tran-DubéPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Paul F RichardsonPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Joseph DerosaDepartment of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Ryan T HelselDepartment of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Ryan L PatmanPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Fen WangPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Christopher P AshcroftPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
John F BraganzaPfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Indrawan McAlpinePfizer Oncology Medicinal Chemistry, 10770 Science Center Drive, San Diego, California 92121, United States.
Peng LiuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.
Keary M EngleDepartment of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.

Funding

Combinatorial, Catalytic Functionalization of Alkenes and AlkynesR35GM125052 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ENGLE, KEARY MARK · 2017 to 2021
$2.9M
Computational Models for Reactivity and Selectivity in Transition Metal-Catalyzed Olefin FunctionalizationR35GM128779 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Peng Liu · 2018 to 2026
$2.9M
General Cross-Metathesis with Vinyl Halides through Catalyst DesignF32GM108145 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ENGLE, KEARY MARK · 2014 to 2015
$61k
NIGMS NIH HHS F32 GM108145NIGMS NIH HHS R35 GM125052NIGMS NIH HHS R35 GM128779
6 · The paper itself

Abstract

The copper-catalyzed hydroboration of benzylidenecyclopropanes, conveniently accessed in one step from readily available benzaldehydes, is reported. Under otherwise identical reaction conditions, two distinct phosphine ligands grant access to different products by either suppressing or promoting cyclopropane opening via β-carbon elimination. Computational studies provide insight into how the rigidity and steric environment of these different bis-phosphine ligands influence the relative activation energies of β-carbon elimination versus protodecupration from the key benzylcopper intermediate. The method tolerates a wide variety of heterocycles prevalent in clinical and pre-clinical drug development, giving access to valuable synthetic intermediates. The versatility of the tertiary cyclopropylboronic ester products is demonstrated through several derivatization reactions.

Indexed as

benzylidenecyclopropanesCopper catalysiscyclopropylboronic estersheterocycleshydroborationsβ-carbon elimination

Identifiers

PMID32617185
PMCPMC7331956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.